Skip Nav

Contact Us

Chondrosarcoma CS Foundation, Inc.

Thank you for your interest in our company. Complete the form below to send us an email, or simply give us a call. We're looking forward to working with you.

  • 301-352-3042

    Author Archives for admin

    Virtual Dialogue Zoom Meeting URL

    November 17, 2020 4:13 pm Published by Comments Off on Virtual Dialogue Zoom Meeting URL

    Last Reminder. We go live at 7:15PM EST (New York time) tonight. We noticed that several of you have tested the connection and are ready to go. If you have any difficulties, Text me at 301-404-7100 We have 109 registrations. Looking forward to your participation. Chondrosarcoma Foundation is inviting you to a scheduled Zoom meeting. [...]


    Virtual Dialogue has 93 Registrations Far Exceeding Expectations

    November 13, 2020 2:19 am Published by Comments Off on Virtual Dialogue has 93 Registrations Far Exceeding Expectations

    In five days, on November 17, at 7:30pm (Eastern Standard Time / New York), the Chondrosarcoma Foundation will host its first Virtual Dialogue: Straight Talk About Chondrosarcoma. We are fortunate to be bringing together a large diverse group consisting of CS patients and family, oncologists, sarcoma specialists, radiology oncologists, pathologists and CS clinical researchers from [...]


    Virtual Dialogue has 93 Registrations Far Exceeding Expectations

    November 13, 2020 2:19 am Published by Comments Off on Virtual Dialogue has 93 Registrations Far Exceeding Expectations

    In five days, on November 17, at 7:30pm (Eastern Standard Time / New York), the Chondrosarcoma Foundation will host its first Virtual Dialogue: Straight Talk About Chondrosarcoma. We are fortunate to be bringing together a large diverse group consisting of CS patients and family, oncologists, sarcoma specialists, radiology oncologists, pathologists and CS clinical researchers from [...]


    Results of A Phase 1 Study on Ivosidenib for Patients with Advanced Chondrosarcoma

    October 23, 2020 4:53 pm Published by Comments Off on Results of A Phase 1 Study on Ivosidenib for Patients with Advanced Chondrosarcoma

    Phase I Study of the Mutant IDH1 Inhibitor Ivosidenib: Safety and Clinical Activity in Patients With Advanced Chondrosarcoma William D. Tap, MD1,2; Victor M. Villalobos, MD, PhD3; Gregory M. Cote, MD, PhD4; Howard Burris, MD5; Filip Janku, MD, PhD6; Olivier Mir, MD, MPH, PhD7; Murali Beeram, MD8; Andrew J. Wagner, MD, PhD9; Liewen Jiang, PhD10; [...]


    Clinical Trial on IDH1 Inhibitor Shows Success in Decreasing Chondrosarcoma Cells

    October 21, 2020 8:08 pm Published by Comments Off on Clinical Trial on IDH1 Inhibitor Shows Success in Decreasing Chondrosarcoma Cells

    Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells Luyuan Li, Ana C. Paz, Breelyn A. Wilky, Britt Johnson, Karina Galoian, Andrew Rosenberg, Guozhi Hu, Gabriel Tinoco, Olaf Bodamer, Jonathan C. Trent Jonathan Trent, M.D., Ph.D. is a world renown leader of [...]


    Invitation to Register for Virtual Dialogue: Straight Talk About Chondrosarcoma

    October 20, 2020 6:13 pm Published by Comments Off on Invitation to Register for Virtual Dialogue: Straight Talk About Chondrosarcoma

    Straight Talk About Chondrosarcoma A Virtual Dialogue (Via Zoom) Tuesday, November 17, 2020 7:30pm – 8:30pm EST www.csfshayna.org/straight-talk-registration/ Please share and circulate this invitation to all Oncologists and Sarcoma Specialists: On Tuesday, November 17, 2020 from 7:30pm -8:30pm EST, the Chondrosarcoma CS Foundation, Inc. will host a virtual dialogue using the zoom platform to reach [...]


    Clinical Research Study by Jonathan Trent on Effectiveness of IDH Inhibitors in Chondrosarcoma

    October 19, 2020 5:53 pm Published by Comments Off on Clinical Research Study by Jonathan Trent on Effectiveness of IDH Inhibitors in Chondrosarcoma

    The Biology and Management of Cartilaginous Tumors: A Role For Targeting Isocitrate Dehydrogenase Gabriel Tinoco, MD, Breelyn A. Wilky, MD, Ana Paz-Mejia, MS, Andrew Rosenberg, MD, Jonathan C. Trent, MD, PhD Jonathan Trent, M.D., Ph.D. is a world renown leader of the Sarcoma, Associate Director, Clinical Research, University of Miami, Sylvester Comprehensive Cancer Center, he [...]


    Medical Book on Sarcoma’s from Jonathan Trent, M.D.

    October 16, 2020 10:04 pm Published by Comments Off on Medical Book on Sarcoma’s from Jonathan Trent, M.D.

    Sarcomas: Evidence-Based Diagnosis and Management Jonathan C. Trent, Andrew E. Rosenberg, Raphael Pollock, Thomas F. Delaney Springer Publishing Company, Incorporated, 2020 – Medical – 434 pages Jonathan Trent, M.D.,Ph.D. is the leader of the Sarcoma Disease Group, Associate Director, Clinical Research, University of Miami, Sylvester Comprehensive Cancer Center, he currently runs a research lab and [...]


    Invitation to Oncologists and Sarcoma Specialists: Register for Virtual Dialogue: Straight Talk About Chondrosarcoma

    October 15, 2020 7:47 pm Published by Comments Off on Invitation to Oncologists and Sarcoma Specialists: Register for Virtual Dialogue: Straight Talk About Chondrosarcoma

    Straight Talk About Chondrosarcoma A Virtual Dialogue (Via Zoom) Tuesday, November 17, 2020 7:30pm – 8:30pm EST www.csfshayna.org/straight-talk-registration/ Please share and circulate this invitation to all Oncologists and Sarcoma Specialists: On Tuesday, November 17, 2020 from 7:30pm -8:30pm EST, the Chondrosarcoma CS Foundation, Inc. will host a virtual dialogue using the zoom platform to reach [...]